Human putative humanin peptide (MT-RNR2) ELISA kits

SOL #: 75N98026Q00243Combined Synopsis/Solicitation

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH OLAO
BETHESDA, MD, 20892, United States

Place of Performance

MD

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

Drugs And Biologicals (6505)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 22, 2026
2
Submission Deadline
May 2, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institute of Aging (NIA) is seeking Human Putative Humanin Peptide (MT-RNR2) ELISA kits for the HANDLS study. This combined synopsis/solicitation aims to procure 49 kits to expand ongoing longitudinal research on age-related chronic diseases, specifically examining the role of humanin in aging and type 2 diabetes. Quotes are due by May 2, 2026, at 4:00 PM EST.

Scope of Work

The requirement is for forty-nine (49) Human Putative Humanin Peptide (MT-RNR2) ELISA Kits (96T size). These kits are essential for quantitatively measuring circulating humanin levels in serum samples from HANDLS participants. The government requires specific kits (CSB-EL015084HU or equal) to ensure continuity of research and comparability with previous pilot study results and published data in human aging cohorts. Key salient characteristics include:

  • ELISA technology, 96-well format.
  • Ability to measure humanin from human serum.
  • Sensitivity to measure humanin at <7 pg/ml.
  • Required serum volume <50 ul.
  • Compatibility with SpectraMax M2 Microplate Reader.
  • Direct comparability with previous research using CSB-EL015084HU.

Contract & Timeline

  • Type: Combined Synopsis/Solicitation (RFQ), Firm Fixed-Price Purchase Order
  • NAICS: 325414 – Biological Product (Except Diagnostic) Manufacturing
  • Set-Aside: None specified
  • Period of Performance: 12 months from award
  • Delivery: Within 2 weeks from receipt and acceptance of award to Baltimore, MD.
  • Quotes Due: May 2, 2026, 4:00 PM EST
  • Published: April 22, 2026

Evaluation

Award will be made to the responsible contractor based on Lowest Price Technically Acceptable (LPTA), considering brand name requirements (salient characteristics), price, and delivery. Offerors must include unit price, list price, shipping, delivery days, prompt payment terms, F.O.B. point, product/catalog number, and description.

Additional Notes

Offerors must be registered in the System for Award Management (SAM) database. All responses must be submitted electronically to johnsonjr@mail.nih.gov.

People

Points of Contact

Files

Files

Download

Versions

Version 1Viewing
Combined Synopsis/Solicitation
Posted: Apr 22, 2026
Human putative humanin peptide (MT-RNR2) ELISA kits | GovScope